HIV Scientific Papers
High levels of treatment success seen with combined use of tesamorelin and GLP1-RAs in people with HIV
2025
Daniel Lee, Claudia Martorell, Edwin Calderon, Zachary Henry, Orin Douglas, Christian Caldji, Colleen S. McGary and Kaitlin Anstett
Reduced muscle quality is highly prevalent in aging People With HIV (PWH) and is associated with excess visceral abdominal fat (EVAF)
2025
Zachary Henry, Gary Sinclair, Karam Mounzer, Jordan E. Lake, John R. Koethe, James G. Terry, Sangeeta Nair, John J. Carr, Mohammed Zogheib, Christian Caldji, and Colleen S. McGary
Efficacy and Safety of 2 Fixed Doses of Ibalizumab Plus Optimized Background Regimen in Treatment-Experienced HIV-Positive Individuals
2024
Edwin DeJesus, MD, William J. Towner, Jr, MD, Joseph C Gathe, MD, R. Brandon Cash, PharmD, and Kaitlin Anstett, PhD
A Prospective and Retrospective Observational Study of Multidrug-Resistant Patient Outcomes with and without Ibalizumab in a Real-World Setting: United States (PROMISE-US) Study Design and Baseline Characteristics
2024
Kumar, P. , Rolle, C., Henry, Z., Emu, B., Martorell, C., McKinnon, J., Slim, J., Cash, R. B. and Anstett, K., on behalf of the PROMISE-US Investigators
Impact of Tesamorelin on Cardiovascular Disease Risk Prediction Scores in Phase 3 Studies Treatment Arms: Subanalysis
2024
S. Grinspoon , L. Fourman , T Stanley , D. Benkeser , C. McGary , R.B. Cash